Two of the largest biopharmaceutical initial public offerings in the US this year – both by companies headquartered outside of the US – were among the latest batch of IPOs. Evotec SE’s $435m offering was the year’s third-largest biopharma IPO and LianBio’s $325m offering closes out the 2021 top 10.
2021's Largest IPOs
-
Sana Biotechnology Inc. $675.6m
The Evotec and LianBio offerings on 3 November and 31 October, respectively, also brought the US biopharma IPO total to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?